USE OF STERILE MEDROXYPROGESTERONE ACETATE SUSPENSION AS A CONTRACEPTIVE DURING A 3-YEAR PERIOD

被引:9
|
作者
DODDS, GH [1 ]
机构
[1] FAMILY PLANNING ASSOC,HONG KONG,HONG KONG
关键词
D O I
10.1016/0010-7824(75)90046-3
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
引用
收藏
页码:15 / 23
页数:9
相关论文
共 50 条
  • [1] Thyroid function during the first year of use of the injectable contraceptive depot medroxyprogesterone acetate
    Quintino-Moro, Alessandra
    Zantut-Wittmann, Denise Engelbrecht
    Silva dos Santos, Priscilla de Nazare
    Melhado-Kimura, Vaneska
    da Silva, Conceicao Aparecida
    Bahamondes, Luis
    Fernandes, Arlete
    [J]. EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2019, 24 (02): : 102 - 108
  • [2] THE CONTRACEPTIVE USE OF DEPOT MEDROXYPROGESTERONE ACETATE
    HICKEY, M
    FRASER, I
    [J]. CLINICAL OBSTETRICS AND GYNECOLOGY, 1995, 38 (04): : 849 - 858
  • [3] EFFECT OF INJECTION VOLUME ON THE BIOAVAILABILITY OF STERILE MEDROXYPROGESTERONE ACETATE SUSPENSION
    WRIGHT, CE
    ANTAL, EJ
    GILLESPIE, WR
    ALBERT, KS
    [J]. CLINICAL PHARMACY, 1983, 2 (05): : 435 - 438
  • [4] Insulin resistance parameters in users of the injectable contraceptive depot medroxyprogesterone acetate during one year of use
    Cursino, Kleber
    Sider, Marina
    Pavin, Elizabeth Joao
    Silva dos Santos, Priscilla de Nazare
    Bahamondes, Luis
    Zantut-Wittmann, Denise Engelbrecht
    Fernandes, Arlete
    [J]. EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2016, 21 (01): : 22 - 29
  • [5] FIBRINOLYTIC-ACTIVITY OF VEINS DURING USE OF DEPOT MEDROXYPROGESTERONE ACETATE AS A CONTRACEPTIVE
    ASTEDT, B
    JEPPSSON, S
    PANDOLFI, M
    [J]. FERTILITY AND STERILITY, 1972, 23 (07) : 489 - &
  • [6] Dietary Intake and Body Composition in New Users of the Injectable Contraceptive Depot-Medroxyprogesterone Acetate During the First Year of Use
    Silva dos Santos, Priscilla de Nazare
    Bahamondes, M. Valeria
    Modesto, Waleska Oliveira
    Bahamondes, Luis
    dos Santos Fernandes, Arlete Maria
    [J]. JOURNAL OF REPRODUCTIVE MEDICINE, 2017, 62 (9-10) : 526 - 533
  • [7] Hyperinsulinemic-euglycemic clamp over the first year of use of depot-medroxyprogesterone acetate as a contraceptive
    Melhado-Kimura, Vaneska
    Batista, Gisele Almeida
    de Souza, Aglecio Luiz
    Silva dos Santos, Priscilla de Nazare
    Alegre, Sarah Monte
    Pavin, Elizabeth Joao
    Bahamondes, Luis
    Fernandes, Arlete
    [J]. CONTRACEPTION, 2018, 98 (02) : 144 - 150
  • [8] Thrombocytopenic purpura with depot medroxyprogesterone acetate and subsequent use of contraceptive implant
    Holman, R
    Stephen, G
    [J]. JOURNAL OF FAMILY PLANNING AND REPRODUCTIVE HEALTH CARE, 2005, 31 (04): : 333 - 334
  • [9] USE OF MEDROXYPROGESTERONE ACETATE AS A CONTRACEPTIVE IN CONJUNCTION WITH EARLY POSTPARTUM RUBELLA VACCINATION
    SHARP, DS
    MACDONALD, H
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1973, 4 (5890): : 443 - 446
  • [10] Lunelle™ monthly contraceptive injection (Medroxyprogesterone acetate and estradiol cypionate injectable suspension):: A contraceptive method for women in the US and worldwide
    Kaunitz, AM
    Mishell, DR
    [J]. CONTRACEPTION, 1999, 60 (04) : 177 - 178